Manufacturers Life Insurance Company, The Neurocrine Biosciences Inc Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 117,252 shares of NBIX stock, worth $16.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117,252
Previous 125,401 6.5%
Holding current value
$16.3 Million
Previous $17.3 Million 21.8%
% of portfolio
0.01%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$114.58 - $153.15 $933,712 - $1.25 Million
-8,149 Reduced 6.5%
117,252 $13.5 Million
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $140,543 - $153,786
1,074 Added 0.86%
125,401 $17.3 Million
Q1 2024

May 14, 2024
BUY
$130.4 - $143.74 $961,308 - $1.06 Million
7,372 Added 6.3%
124,327 $17.1 Million
Q4 2023

Feb 13, 2024
BUY
$106.07 - $132.76 $1.92 Million - $2.4 Million
18,070 Added 18.27%
116,955 $15.4 Million
Q3 2023

Nov 15, 2023
BUY
$94.02 - $117.1 $408,516 - $508,799
4,345 Added 4.6%
98,885 $11.1 Million
Q2 2023

Aug 11, 2023
SELL
$89.53 - $104.87 $588,838 - $689,729
-6,577 Reduced 6.5%
94,540 $8.92 Million
Q1 2023

May 15, 2023
SELL
$94.11 - $123.02 $268,495 - $350,976
-2,853 Reduced 2.82%
98,264 $9.95 Million
Q4 2022

Aug 11, 2023
SELL
$106.72 - $127.06 $137,668 - $163,907
-1,290 Reduced 1.26%
101,117 $12.1 Million
Q4 2022

Feb 13, 2023
SELL
$106.72 - $127.06 $137,668 - $163,907
-1,290 Reduced 1.26%
101,117 $12.1 Million
Q3 2022

Aug 11, 2023
BUY
$92.03 - $107.81 $66,997 - $78,485
728 Added 0.72%
102,407 $10.9 Million
Q3 2022

Nov 03, 2022
BUY
$92.03 - $107.81 $66,997 - $78,485
728 Added 0.72%
102,407 $10.8 Million
Q2 2022

Aug 11, 2023
BUY
$75.79 - $100.07 $133,996 - $176,923
1,768 Added 1.77%
101,679 $9.91 Million
Q2 2022

Aug 15, 2022
BUY
$75.79 - $100.07 $133,996 - $176,923
1,768 Added 1.77%
101,679 $9.93 Million
Q1 2022

Aug 11, 2023
BUY
$72.45 - $94.81 $119,325 - $156,152
1,647 Added 1.68%
99,911 $9.37 Million
Q1 2022

May 20, 2022
SELL
$72.45 - $94.81 $524,030 - $685,760
-7,233 Reduced 6.75%
99,911 $9.34 Million
Q4 2021

Feb 16, 2022
SELL
$79.65 - $106.22 $146,794 - $195,763
-1,843 Reduced 1.69%
107,144 $9.12 Million
Q3 2021

Nov 12, 2021
BUY
$86.18 - $99.03 $470,973 - $541,198
5,465 Added 5.28%
108,987 $10.5 Million
Q2 2021

Aug 12, 2021
SELL
$89.43 - $102.27 $629,318 - $719,673
-7,037 Reduced 6.36%
103,522 $10.1 Million
Q1 2021

May 03, 2021
BUY
$87.57 - $119.4 $9.68 Million - $13.2 Million
110,559 New
110,559 $10.8 Million
Q3 2020

Nov 09, 2020
SELL
$96.16 - $135.15 $185,684 - $260,974
-1,931 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$85.09 - $130.36 $164,308 - $251,725
1,931 New
1,931 $242,000
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $172,001 - $260,510
-2,290 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$86.8 - $118.57 $7,378 - $10,078
-85 Reduced 3.58%
2,290 $246,000
Q3 2019

Nov 12, 2019
SELL
$83.82 - $101.5 $9,555 - $11,571
-114 Reduced 4.58%
2,375 $214,000
Q2 2019

Aug 14, 2019
BUY
$72.24 - $91.27 $179,805 - $227,171
2,489 New
2,489 $210,000
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $150,918 - $274,711
-2,209 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $29,861 - $38,006
-302 Reduced 12.03%
2,209 $272,000
Q2 2018

Aug 14, 2018
SELL
$75.3 - $105.99 $978 - $1,377
-13 Reduced 0.52%
2,511 $247,000
Q1 2018

May 15, 2018
SELL
$75.88 - $92.43 $8,877 - $10,814
-117 Reduced 4.43%
2,524 $209,000
Q4 2017

Feb 08, 2018
SELL
$58.53 - $77.59 $4,389 - $5,819
-75 Reduced 2.76%
2,641 $205,000
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $130,286 - $166,436
2,716
2,716 $167,000

Others Institutions Holding NBIX

# of Institutions
626
Shares Held
94M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.3B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email